NCT05701579 Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment
| NCT ID | NCT05701579 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Artromedical Konrad Malinowski Clinic |
| Condition | Anterior Cruciate Ligament Injuries |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2022-07-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2022-07-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.
Eligibility Criteria
Inclusion Criteria: * patients with ACL degeneratio mucosa decided to undergo a surgical treatment * range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI Exclusion Criteria: * non-adherence to the study protocol * active knee inflammation * range of motion impairment due to other extra- and intra-articular reasons
Contact & Investigator
Konrad Malinowski, MD PhD
PRINCIPAL INVESTIGATOR
Artromedical Orthopaedic Clinic, Bełchatów, Poland
Frequently Asked Questions
Who can join the NCT05701579 clinical trial?
This trial is open to participants of all sexes, studying Anterior Cruciate Ligament Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05701579 currently recruiting?
Yes, NCT05701579 is actively recruiting participants. Contact the research team at malwin8@wp.pl for enrollment information.
Where is the NCT05701579 trial being conducted?
This trial is being conducted at Bełchatów, Poland.
Who is sponsoring the NCT05701579 clinical trial?
NCT05701579 is sponsored by Artromedical Konrad Malinowski Clinic. The principal investigator is Konrad Malinowski, MD PhD at Artromedical Orthopaedic Clinic, Bełchatów, Poland. The trial plans to enroll 10 participants.